ELEV (elevationoncology.com) Yalpi marja

ELEV (Elevation Oncology, Inc.) - kompaniyaning tovar belgisi

Makroiqtisodiyotdan mustaqillik sektorni defensiv qiladi va GURU.Markets platformasida ushbu chiziqli yalpi foyda foizi modelning barqarorligini tasdiqlaydi, bunda so'nggi parametr 0.00 hisoblanadi. Elevation Oncology (ELEV) kompaniyasining samaradorligi noyob mutatsiyalar uchun aniq terapiyaga asoslangan bo'lib, bu genetik diagnostika bilan bir qatorda bozorni kengaytiradi. Murakkab o'smalarni davolashga yondashuvning shaxsiylashtirilgan usuli biofarmatsevtika risklarini yanada minimallashtiradi.

Elevation Oncology, Inc. (ELEV) - Yalpi marja 04.07.2022dan 02.08.2025gacha

Elevation Oncology, Inc. (ELEV) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:Elevation Oncology Inc. (ELEV)
elevationoncology.com brend mahsuloti

Operatsion samaradorlik Elevation Oncology (ELEV) uchun juda muhimdir, chunki uning muvaffaqiyati bozor sikllariga emas, balki klinik sinovlarga bog'liq. Ushbu ko'rsatkich daromad va sotuvlarning bevosita xarajatlari orasidagi farq sifatida hisoblanadi hamda kompaniyaning ma'muriy xarajatlarni chegirib tashlashdan oldin o'z ishlanmalarini monetizatsiya qilish qobiliyatini o'lchaydi. Vald profitsiya marjasini tahlil qilish investorga terapiya ishlab chiqarishning haqiqiy xarajatlarini va biznesning fundamental barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|AONC - Yalpi rentabellik|BGNE: Yalpi rentabellik|CKPT: Yalpi marja|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik